A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects. - Yurgelun-Todd, Deborah A.; Renshaw, Perry F.; Goldsmith, Paul; Uz, Tolga; Macek, Thomas A. (Psychopharmacology, 2020)